Indobufen tablets are mainly used for ischemic cardiovascular lesions due to atherosclerosis, ischemic cerebrovascular and peripheral vascular diseases, formation of venous thrombosis, replacing antiplatelet agents such as aspirin, reducing the risk of bleeding, and also preventing thrombosis during extracorporeal circulation surgery. Common adverse reactions such as dyspepsia, abdominal discomfort, constipation, nausea and vomiting, headache and dizziness, allergic skin reactions, bleeding gums, epistaxis (nosebleed); and in a few cases, gastric ulcers, gastrointestinal bleeding, or hematuria, may occur after administration of indobufen tablets. Stop the drug immediately if there is hives-like skin allergy. Indobufen tablets are contraindicated in patients who are allergic to the components of indobufen tablets; in patients with congenital or acquired bleeding disorders; in pregnant and lactating women. Patients with active lesions of the gastrointestinal tract should be cautious, the use of non-steroidal anti-inflammatory drugs should not be used during the use of the drug, 65 years old patients should be used with caution. If you need to use this drug, please consult a professional doctor, follow the doctor’s instructions, reasonable use of medication.